Epidural hematoma and abscess
Stem
A 71-year-old woman, 68 kg, is on postoperative day 1 after an open right hemicolectomy. A T9–T10 epidural catheter is running bupivacaine 0.1% with hydromorphone. She receives enoxaparin 40 mg once daily; the last dose was 8 hours ago. At 0600 she moved both legs normally. At 1100 the nurse calls: she cannot lift either leg, her thighs are numb, and she has new mid-back pain.
Question
What is going on, and what do you do right now?
Ideal answer
HeadlineEpidural hematoma until proven otherwise, and the clock is running. I go to the bedside myself.
- Examine against the morning exam. Motor strength, sensory level, saddle anesthesia, urinary retention: a dilute thoracic infusion should not produce a dense bilateral leg block, so new weakness is a red flag.
- Stop the infusion now, because a drug block should regress; I wait only briefly.
- Hold tonight's enoxaparin, send platelets and coagulation studies, call surgeon and neurosurgery before the scan, since outcome depends on decompression speed; emergent thoracolumbar MRI.
- The catheter stays in for now, because pulling it soon after a dose can itself bleed; out ≥12 hours after the last prophylactic dose; next dose ≥4 hours after removal.1
- Hematoma means laminectomy, ideally within 8 hours of onset, when recovery is far likelier.1
Watch for: Neurologic checks until the operating room; exact times documented.
Breaking down the answer
- Name the diagnosis in the first sentence — new or progressive motor block was the presenting feature in 83% of closed-claims hematomas, while back pain was present in only 25%;1 waiting for pain is the classic error.
- Dilute on purpose — a weak solution is chosen precisely so that a hematoma is not masked.1 Changes if: the block keeps spreading after the infusion stops, which ends the waiting.
- After 24 hours, outcomes are poor — decompression within 8 hours gave the best recoveries, and patients operated after 24 hours mostly did poorly;1 mobilizing the surgeon in parallel with the MRI saves the hours that matter.
- Know the risk factors — older age, female sex, renal impairment, traumatic or repeated puncture, catheter manipulation, and anticoagulation; the historical incidence was under 1 in 150,000 epidurals, but 1 in 3,600 in elderly women after knee arthroplasty.1
- LMWH timing at the catheter — once-daily prophylaxis with a catheter in is acceptable; Changes if: twice-daily, which carries more risk, so the catheter comes out before it starts.1 The ASRA fifth edition (2025) keeps the same low-dose intervals (neuraxial-anticoagulation-guidelines page).
- Keep abscess in the differential — it presents later, over days, with fever and back pain; the scan that diagnoses one also diagnoses the other.
Follow-up question
The MRI is normal and the weakness resolves after stopping the infusion. On day 4 she has a temperature of 38.6 °C, worsening back pain, and redness and tenderness at the catheter site, with intact leg strength. What now?
Follow-up answer
HeadlinePossible epidural abscess, urgent though she is intact: the classic triad of back pain, fever and deficit is present in only 7.9% of cases.2
The deficit is the late sign. I tell her and the surgical team what I suspect. I remove the catheter, timed to her enoxaparin, and send the tip and a site swab for culture with two sets of blood cultures, then an emergent gadolinium-enhanced MRI.2 After cultures, empirical antibiotics covering Staphylococcus aureus, about two-thirds of cases, with infectious disease and neurosurgery involved.2 A collection with any deficit is decompressed as soon as possible;2 antibiotics alone are for selected patients without a deficit. I examine her neurologically every few hours.
Pitfalls that cost points
- Pulling the catheter immediately while enoxaparin is at peak effect.
- Dismissing an abscess because she has no deficit.
Rapid-fire
Q: What is the single most useful protective step for a catheter on a surgical ward? A: A dilute local anesthetic and scheduled neurologic checks, so a new motor block stands out.1
Q: Which imaging study, and why not CT? A: MRI, because it shows the cord and the epidural space; CT is a fallback only when MRI is unavailable.
Q: Which organism do you cover first in an abscess? A: Staphylococcus aureus, which causes about two-thirds of cases;2 I cover MRSA too until cultures return.
Q: Name two host risk factors for an abscess. A: Diabetes, the most consistent one, and IV drug use; spinal trauma is another.2
Q: What changes with twice-daily prophylactic LMWH? A: The catheter is removed before the first dose, because that regimen carries a higher hematoma risk.1
Numbers to know
| Item | Value |
|---|---|
| Historical hematoma incidence | <1:150,000 epidural; <1:220,000 spinal1 |
| Elderly women after knee arthroplasty | 1:3,6001 |
| Presenting sign (closed claims) | Motor block 83%, back pain 25%1 |
| Decompression window | Within 8 h of symptom onset1 |
| Prophylactic LMWH and catheter | Remove ≥12 h after dose; next dose ≥4 h after removal1 |
| Abscess classic triad present | 7.9%2 |
| S. aureus share of abscesses | About two-thirds2 |
Links
- Neuraxial blocks and anticoagulants (ASRA), Epidural anesthesia and the test dose, Thoracic epidural analgesia, Spinal anesthesia: dosing, spread, hypotension, Disclosing a peri-procedural complication or error
- ASRA Pain Medicine guidelines on regional anesthesia and antithrombotic therapy (fifth edition, 2025)
Sources
- 1.Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: ASRA Evidence-Based Guidelines (Fourth Edition) · ASRA, 2018 · history.mayoclinic.orgSource of incidence, presenting-symptom data, the 8-hour laminectomy window and the LMWH intervals on this page; the fifth edition (2025) summary at guidelinecentral.com could not be fetched this session, so check intervals against it.
- 2.Spinal epidural abscess · ACP Hospitalist, 2023 · acphospitalist.acponline.orgClassic triad in 7.9%; MSSA about two-thirds; emergent gadolinium MRI; decompression as soon as possible.
Facts on this page were checked against these sources on Oct 15, 2026. Guidelines change; confirm doses against current institutional protocols.